Directory
|
The Wistar Institute EBV drug discovery |
University of Manchester All multiple sclerosis, cognitive dysfunction in MS, mental health in MS, identity in MS, Neuromyelitis optica |
|
University of Calgary clinical trials, epidemiology |
Millennium/Takeda Biomarkers, Drug Development |
|
54 28 |
98 86 |
|
78 68 |
90 14 |
|
86 47 |
Alzforum Neurological Disorders |


